help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nilsson, B.
Right arrow Articles by Jonsson, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nilsson, B.
Right arrow Articles by Jonsson, B.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 4 1420-1425
Copyright © 2000 by The Endocrine Society

Original Studies

Pituitary Adenomas in Sweden between 1958 and 1991: Incidence, Survival, and Mortality1

Bo Nilsson, Evi Gustavsson-Kadaka, Bengt-Åke Bengtsson and Björn Jonsson

Department of Cancer Epidemiology, Karolinska University Hospital (B.N., E.G.-K.), SE-17176 Stockholm; Research Center for Endocrinology and Metabolism, Sahlgrenska University Hospital (B.-Å.B.), SE-41345 Goteborg; and Department of Women and Child Health, St. Goran’s Hospital, Karolinska Institute (B.J.), SE-17177 Stockholm, Sweden

Address all correspondence and requests for reprints to: Prof. Bengt-Åke Bengtsson, Research Center for Endocrinology and Metabolism, Sahlgrenska University Hospital, SE-41345 Goteborg, Sweden.

The objective of the present study was to determine the incidence of pituitary adenomas (PAs) and the associated rates and causes of mortality in a large population. The study population comprised 2279 patients (1010 women and 1269 men) of all individuals (n = 3321) with pituitary tumors included in the Swedish Cancer Registry between 1958 and 1991. The mean age (±SD) at diagnosis was 52.3 ± 15.7 yr. The age-standardized incidence of PA increased significantly from approximately 6 cases/million inhabitants in 1958 to 11 cases/million in 1991. The age-specific incidence peaked between 60–70 yr of age in both sexes. Excess mortality was found in the study population. The total number of deaths was 842. The standardized mortality ratio (SMR) for the study population was 2.0. The SMR for women (2.3) was significantly (P < 0.01) higher than that for men (1.9). Cardiovascular diseases were the most common cause of mortality among patients, accounting for 346 deaths (SMR, 1.6). The difference between the sexes was significant (men, 1.4; women, 1.8; P < 0.05). Cerebrovascular death occurred in 97 patients (SMR, 2.4), with no significant difference between men (SMR, 2.5) and women (SMR, 2.2). Excess mortality was also observed for tumors, endocrine diseases, and gastrointestinal diseases. These findings suggest that the annual incidence of PA is increasing. Possible explanations are improved diagnostic skill and/or increased awareness of pituitary diseases among physicians. However, a real increase in the incidence of PA cannot be ruled out.




This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
A. C. Pesatori, A. Baccarelli, D. Consonni, A. Lania, P. Beck-Peccoz, P. A. Bertazzi, and A. Spada
Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident
Eur. J. Endocrinol., December 1, 2008; 159(6): 699 - 703.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
K. Stochholm, C. H. Gravholt, T. Laursen, P. Laurberg, M. Andersen, L. O. Kristensen, U. Feldt-Rasmussen, J. S. Christiansen, M. Frydenberg, and A. Green
Mortality and GH deficiency: a nationwide study
Eur. J. Endocrinol., July 1, 2007; 157(1): 9 - 18.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
O. M. Dekkers, N. R. Biermasz, A. M. Pereira, F. Roelfsema, M. O. van Aken, J. H. C. Voormolen, and J. A. Romijn
Mortality in Patients Treated for Cushing's Disease Is Increased, Compared with Patients Treated for Nonfunctioning Pituitary Macroadenoma
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 976 - 981.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
E. Ferrante, M. Ferraroni, T. Castrignano, L. Menicatti, M. Anagni, G. Reimondo, P. Del Monte, D. Bernasconi, P. Loli, M. Faustini-Fustini, et al.
Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors
Eur. J. Endocrinol., December 1, 2006; 155(6): 823 - 829.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. F. Daly, M. Rixhon, C. Adam, A. Dempegioti, M. A. Tichomirowa, and A. Beckers
High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liege, Belgium
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4769 - 4775.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. E. Molitch, D. R. Clemmons, S. Malozowski, G. R. Merriam, S. M. Shalet, M. L. Vance, and for The Endocrine Society's Clinical Guidelines Su
Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1621 - 1634.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
V K B Prabhakar and S M Shalet
Aetiology, diagnosis, and management of hypopituitarism in adult life.
Postgrad. Med. J., April 1, 2006; 82(966): 259 - 266.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
A. S. Dumont, E. C. Nemergut II, J. A. Jane Jr, and E. R. Laws Jr
Postoperative Care Following Pituitary Surgery
J Intensive Care Med, May 1, 2005; 20(3): 127 - 140.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. K. Miller, B. M. K. Biller, J. G. Lipman, G. Bradwin, N. Rifai, and A. Klibanski
Truncal Adiposity, Relative Growth Hormone Deficiency, and Cardiovascular Risk
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 768 - 774.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Svensson, B.-A. Bengtsson, T. Rosen, A. Oden, and G. Johannsson
Malignant Disease and Cardiovascular Morbidity in Hypopituitary Adults with or without Growth Hormone Replacement Therapy
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3306 - 3312.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. B. Twickler, M. J. M. Cramer, G. M. Dallinga-Thie, M. J. Chapman, D. W. Erkelens, and H. P. F. Koppeschaar
Adult-Onset Growth Hormone Deficiency: Relation of Postprandial Dyslipidemia to Premature Atherosclerosis
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2479 - 2488.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. B. Twickler, G. M. Dallinga-Thie, F. L. J. Visseren, W. R. de Vries, D. W. Erkelens, and H. P. F. Koppeschaar
Induction of Postprandial Inflammatory Response in Adult Onset Growth Hormone Deficiency Is Related to Plasma Remnant-Like Particle-Cholesterol Concentration
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1228 - 1233.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society